POSITIVE IN VITRO DATA FOR CHM 1301 CAR NK CELLS IN OVARIAN AND
PANCREATIC CANCERS
Positive preclinical data for CHM 1301, a next generation off the shelf CLTX CAR NK cell therapy
Up to 300% enhanced cell killing demonstrated compared to first generation NK cells
Evidence of expansion into two new solid tumours – pancreatic cancer and ovarian cancer
CHM 1301 program to advance to the next stage of preclinical development under academic
research collaboration
- Forums
- ASX - By Stock
- Ann: Positive in vitro data for CHM 1301 CAR NK cells
POSITIVE IN VITRO DATA FOR CHM 1301 CAR NK CELLS IN OVARIAN AND...
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.39M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.1¢ | $9.791K | 466.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 1322541 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 99000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 1322541 | 0.020 |
5 | 739999 | 0.019 |
6 | 348975 | 0.018 |
3 | 419425 | 0.017 |
10 | 1343217 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 99000 | 1 |
0.022 | 958675 | 6 |
0.023 | 250000 | 2 |
0.024 | 400000 | 3 |
0.025 | 545000 | 2 |
Last trade - 14.13pm 26/07/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |